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Purpose: To scan a volunteer population using 3.0T magnetic resonance imaging (MRI). MRI of the left ventricular (LV)
structure and function in healthy volunteers has been reported extensively at 1.5T.
Materials and Methods: A population of 1528 volunteers was scanned. A standardized approach was taken to acquire
steady-state free precession (SSFP) LV data in the short-axis plane, and images were quantified using commercial soft-
ware. Six observers undertook the segmentation analysis.
Results: Mean values (6standard deviation, SD) were: ejection fraction (EF) 5 69 6 6%, end diastolic volume index
(EDVI) 5 71 6 13 ml/m2, end systolic volume index (ESVI) 5 22 6 7 ml/m2, stroke volume index (SVI) 5 49 6 8 ml/m2,
and LV mass index (LVMI) 5 55 6 12 g/m2. The mean EF was slightly larger for females (69%) than for males (68%), but
all other variables were smaller for females (EDVI 68v77 ml/m2, ESVI 21v25 ml/m2, SVI 46v52 ml/m2, LVMI 49v64 g/m2,
all P < 0.05). The mean LV volume data mostly decreased with each age decade (EDVI males: –2.9 6 1.3 ml/m2,
females: –3.1 6 0.8 ml/m2; ESVI males: –1.3 6 0.7 ml/m2, females: –1.7 6 0.5 ml/m2; SVI males: –1.7 6 0.9 ml/m2,
females: –1.4 6 0.6 ml/m2; LVMI males: –1.6 6 1.1 g/m2, females: –0.2 6 0.6 g/m2) but the mean EF was virtually stable
in males (0.6 6 0.6%) and rose slightly in females (1.2 6 0.5%) with age.
Conclusion: LV reference ranges are provided in this population-based MR study at 3.0T. The variables are similar to
those described at 1.5T, including variations with age and gender. These data may help to support future population-
based MR research studies that involve the use of 3.0T MRI scanners.
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The use of cardiac magnetic resonance (MR) for theassessment of left ventricular (LV) structure and func-
tion is a well-established technique that is used for both
clinical and research investigations. Volunteer “normal
ranges” have been published for data acquired on 1.5T sys-
tems,1–3 with an emphasis on the use of the steady state-
gradient echo sequence since the associated T2/T1 weighting
provides excellent contrast between the myocardium and the
blood pool. Other research groups have extended this work
to acquire MR LV data on larger-scale populations. Exam-
ples of these include the following studies: Framingham
Offspring,4 Dallas Heart,5 MESA,6 AGES Reykjavik,7 Ger-
man SHIP,8 and Lichfield LARGE Heart.9 Further large-
scale investigations such as the UK Biobank10 are also in
progress. However, to date all population-based cardiac MR
studies have been conducted using 1.5T scanners.
With the increasing use of 3.0T MR scanners for clin-
ical imaging, there is a need to establish equivalent data for
images acquired at this higher field strength.11 Small com-
parison studies of 1.5T vs. 3.0T MR in healthy volunteers
have previously been undertaken.12,13 Recent work from Liu
et al has reported the use of a 3.0T MR system for MR
scanning of a population of healthy African Americans,14
although it is known from previous work that ethnic varia-
tions in LV structure and function do exist,15 so there might
be a need to extend this work to a European setting.
Early MR investigations that used 3.0T machines
tended to recommend the use of spoiled gradient echo
imaging since it was less susceptible to flow-related arti-
facts.16 However, with the development over time of better
shimming techniques, the steady-state sequence has become
the sequence of choice for MR at 3.0T.17
The T1 and T2 relaxation times of tissues are inher-
ently affected by the local magnetic field strength to which
they are exposed, and T1 relaxation times in particular are
elevated at higher field strengths.18 In cardiac MR, since the
process of computer segmentation involves the precise delin-
eation of myocardial boundaries, it therefore follows that
boundary delineation could be perceived differently at 1.5T
and 3.0T due to possible variations in myocardium-blood
contrast-to-noise ratio (CNR).19 Such systematic differences
could be clinically important in cases where particular LV
“cutoff” values are used to determine the future course of
patient treatments; or in longitudinal investigations where
comparisons may involve datasets acquired on machines of
different field strengths. From a clinical perspective, since
LV hypertrophy is an indicator of many underlying cardiac
conditions and can also be a strong independent predictor
for incident cardiovascular events, a precise definition of
population-based ranges is required.20
The objective of this study therefore was to use MR to
examine the LV structure and function of a large UK popu-
lation of volunteers using a standard steady-state gradient
echo sequence on a 3.0T scanner in order to establish popu-
lation range data capable of comparison with similar data
acquired at 1.5T.
Materials and Methods
This MR study was conducted as part of a wider population-based
cardiovascular MR investigation of volunteers asymptomatic of car-
diovascular disease (CVD) (the Tayside Screening for the Preven-
tion of Cardiac Events [TASCFORCE] study). The study was
allocated an International Standard Randomised Control Trial
Number: ISRCTN38976321. Local research ethical committee
(REC) approval for the work was obtained and all volunteers gave
informed consent. A total of 1528 volunteers were included in the
study, which ran from June 2008 until February 2013. Inclusion
criteria were as follows: 1) age 40 years; 2) free from CVD or
other indication for statin therapy as recommended by the Scottish
Intercollegiate Guidelines Network (SIGN) report 97 (www.sign.
ac.uk) published in February 2007; 3) 10-year risk of coronary
heart disease below 20% as predicted by the Adult Treatment Panel
III (ATPIII) algorithm21; and 4) a plasma B type natriuretic pep-
tide (BNP) level greater than the gender specific median. Exclusion
criteria included: i) pregnancy; ii) known primary muscle disease;
iii) known atherosclerotic disease, including unstable angina, previ-
ous myocardial infarction, peripheral arterial disease, amputation,
revascularization, hypertension, heart failure, or cerebrovascular
event; iv) known diabetes; v) active liver disease; vi) other known
illness or contraindication to MR; vii) participation in a clinical
trial; viii) inability to give informed consent; ix) known alcohol
abuse; and x) blood pressure (BP) of greater than 145/95 mmHg.
Each volunteer was grouped into a “decade band” based on
their age at the time of the investigation. The decade bands were
defined by age as follows: 1) the “40s” (40–49 years); 2) the “50s”
(50–59 years); 3) the “60s” (60–69 years); and 4) the “over 70s”
(70 years).
The MR protocol has been described in detail elsewhere,22 but
in brief imaging was performed in the head-first supine orientation
using a 3T [102x32] Scanner (Magnetom Trio, Siemens, Erlangen,
Germany). A body matrix radiofrequency (RF) coil (six elements) was
used in combination with a spine array (up to 24 elements).
Three plane localizer steady-state gradient echo images of the
heart were initially obtained using a true fast imaging with steady-
state free precession (TrueFISP) sequence, and these were followed
by the acquisition of further localizers in the cardiac two-chamber
(2ch), four-chamber (4ch), and short axis (SA) orientations. Subse-
quently, electrocardiogram (ECG)-gated segmented breath-hold
cinematic (CINE) TrueFISP images were acquired in the LV 4ch
and 2ch orientations, and a stack of SA images were acquired from
the atrio-ventricular ring to the LV apex using 2D ECG-gated
breath-hold segmented CINE TrueFISP sequence with retrospective
gating. The sequence parameters for the short-axis acquisitions
were: TR/TE 5 3.4/1.5 msec, flip angle >508, field of view >360
mm (volunteer dependent), pixel matrix 173 3 256, slice thickness
6 mm and interslice gap 4 mm (slices acquired every 10 mm). Ret-
rospective ECG gating was used, with 25 cardiac phases recon-
structed (25 lines per segment) and two image slices acquired per
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breath-hold. Parallel imaging was also implemented (integrated
parallel acquisition technique, iPAT x2), resulting in a scan time of
<15 seconds per breath-hold.
Image Analysis
All datasets were analyzed once by one member of a team of six
medical physics observers (S.G., R.N., J.M., S.W., S.M., and I.C.,
cardiac MR experience ranging from 7 to 12 years). This was per-
formed on a rotational basis in order to ensure (as far as possible)
that each observer was responsible for segmenting an equal number
of datasets. The images were analyzed using Argus (Siemens Multi-
modality Work Platform, VB15 and VB17). Region of interest
(ROI) contours were placed around endocardial and epicardial LV
borders on all image slices at end-diastole and end-systole that con-
tained 50% or more full-thickness myocardium. Quantitative
measurements of ejection fraction (EF), end-diastolic volume
(EDV), end-systolic volume (ESV), stroke volume (SV), and LV
mass (LVM) (at end-diastole) were derived. Papillary muscles were
included in the LVM if visually indistinguishable from the myocar-
dial wall, but otherwise assigned to the left ventricular blood pool.
As far as possible (within the constraints of the software capability)
the adopted methodology was performed as per the guidance notes
provided by Schulz-Menger et al.23
Statistical Analysis
All original study participants were included in the baseline analy-
sis, as a representative UK population of individuals asymptomatic
of CVD. A subanalysis of the full cohort was also performed in
order to identify those volunteers (“subset cohort”; n 5 782) who,
in addition to being asymptomatic, had more stringent low-risk
factor criteria for future CVD. Participants were assigned to this
subset if they had BP < 140/90 mmHg and no history of smok-
ing,6 together with plasma BNP lower than 2 SDs above the full
cohort gender-specific mean (30.60 pg/ml for men and 53.36 pg/
ml for women).
Normalization of MR LV data to body surface area (BSA)
was performed using the simple formula described by Mosteller.24
Data were presented as mean 6 SD in all cases.
Comparison of the mean values of each LV parameter
between male and female cohorts was performed using a Student’s
t-test, with P < 0.05 indicating significant differences between the
two genders. The association of all LV parameters with age (for
each gender) was evaluated, and a one-way analysis of variance
(ANOVA) (with Tukey post-hoc analysis) was performed (four
samples per gender) in order to identify statistical differences
between the mean values of each of these variables with age.
Regression analysis was also performed to investigate the various
associations between each LV variable and age. From this, a “per
decade” change in each variable was calculated, based on the
assumption that the changes were linear with age. A formal assess-
ment of intra- and interobserver repeatability has not been pre-
sented since this is reported elsewhere.22 However, reasonable
estimates of interobserver variation can be extracted from the data
generated by different segmentation observers because each of the
respective cohorts were age-matched, gender-matched, and normal-
ized to BSA. Comparison of 3T data versus 1.5T data was per-
formed by tabulating the pooled data reported by Kawel-Boehm
et al11 against the data acquired in this study. Data were presented
for both field strengths as a mean 6 SD for all LV variables, and
stratified according to gender. Full data ranges for each LV variable
were also recorded. Differences between the means of each variable
TABLE 1. Demographic Information Related to Anatomical Size for All Volunteers in the Study
ABSOLUTE No
Volunteers
Height (m) Weight (kg) BMI
(kg/m2)
BSA
(Mosteller)
BSA
(DuBois)
All 1515 (100%) 1.69 (0.09) 75.04 (14.31) 26.18 (4.23) 1.87 (0.21) 1.85 (0.20)
Males 574 (37.9%) 1.77 (0.07) 83.53 (12.28) 26.52 (3.50) 2.02 (0.17) 2.01 (0.16)
Females 941 (62.1%) 1.64 (0.07) 70.54 (13.00) 26.25 (4.44) 1.79 (0.18) 1.76 (0.16)
Males (40s) 197 (13.0%) 1.79 (0.07) 85.02 (12.65) 26.59 (3.53) 2.05 (0.17) 2.03 (0.16)
Males (50s) 235 (15.5%) 1.77 (0.07) 84.11 (12.13) 26.72 (3.41) 2.03 (0.17) 2.01 (0.15)
Males (60s) 118 (7.7%) 1.76 (0.06) 80.68 (11.61) 26.13 (3.46) 1.98 (0.16) 1.96 (0.15)
Males (70s) 24 (1.6%) 1.76 (0.06) 79.72 (11.41) 25.95 (4.27) 1.97 (0.15) 1.95 (0.13)
Females (40s) 318 (21.0%) 1.65 (0.07) 72.09 (14.33) 26.48 (4.98) 1.81 (0.19) 1.79 (0.17)
Females (50s) 371 (24.5%) 1.64 (0.07) 70.43 (12.64) 26.22 (4.65) 1.78 (0.17) 1.76 (0.15)
Females (60s) 213 (14.1%) 1.63 (0.06) 66.50 (10.71) 25.05 (3.95) 1.73 (0.15) 1.71 (0.14)
Females (70s) 39 (2.6%) 1.62 (0.07) 64.61 (9.55) 24.56 (3.55) 1.70 (0.14) 1.69 (0.13)
Data are stratified by gender and age, and other parameters such as mean body mass index (BMI) and mean body surface area (BSA)
are included. The mean BSA was calculated using the formulae described by Mosteller24 (BSA Mosteller) and DuBois-DuBois29 (BSA
DuBois). The values for height, weight, BMI and BSA are represented as means - with standard deviations alongside in parentheses.
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were calculated by simple subtraction in order to estimate whether
the LV variable means varied randomly between 1.5T and 3.0T, or
whether the means were systematically different. All statistical test-
ing was performed using SPSS (IBM, Armonk, NY).
Results
A total of 1515 volunteers were scanned successfully, and a
description of demographic information related to anatomic
size is shown in Table 1. A further n 5 13 volunteers were
also scanned (original study size n 5 1528) but were
excluded from the analysis as a result of either radiographic
error or significant movement artifacts experienced during
the MR scanning process.
A summary of the results is shown in Table 2. When
the normalized data from all female and male participants
were examined together the mean EF was higher for females
(P < 0.05), but all other variables (EDV, ESV, SV, and
LVM) were higher for males (all P < 0.05).
TABLE 2. LV Structure and Function Data Acquired on a Cohort of 1515 Volunteers
ABSOLUTE No Volunteers EF (%) EDV (ml) ESV (ml) SV (ml) LVM (g)
All 1515 (100%) 696 6 1336 29 426 15 916 19 1036 29
Males 574 (37.9%) 686 6 1556 28 506 15 1056 19 1296 24
Females 941 (62.1%) 696 7 1206 21 376 12 826 14 876 17
Males (40s) 197 (13.0%) 676 6 1636 27 546 13 1096 20 1356 27
Males (50s) 235 (15.5%) 686 6 1536 27 496 15 1046 18 1286 22
Males (60s) 118 (7.7%) 686 7 1476 26 476 15 1006 17 1236 21
Males (70s) 24 (1.6%) 686 6 1436 32 476 15 976 21 1226 24
Females (40s) 318 (21.0%) 686 6 1276 20 416 11 866 14 886 17
Females (50s) 371 (24.5%) 696 7 1216 21 386 12 836 14 886 17
Females (60s) 213 (14.1%) 716 7 1106 19 336 12 786 12 846 16
Females (70s) 39 (2.6%) 726 6 1046 18 306 10 746 12 816 15
NORMALISED No
Volunteers
EF
(%)
EDVI
(ml/m2)
ESVI
(ml/m2)
SVI
(ml/m2)
LVMI
(g/m2)
All 1515 (100%) 696 6 716 13 226 7 496 8 556 12
Males 574 (37.9%) 686 6 776 13 256 7 526 9 646 10
Females 941 (62.1%) 696 7 686 11 216 7 466 7 496 8
Males (40s) 197 (13.0%) 676 6 806 13 266 7 536 9 666 12
Males (50s) 235 (15.5%) 686 6 766 13 246 8 526 9 636 10
Males (60s) 118 (7.7%) 686 7 746 13 246 8 516 9 626 10
Males (70s) 24 (1.6%) 686 6 736 14 246 7 496 9 626 10
Females (40s) 318 (21.0%) 686 6 706 10 226 6 486 7 496 8
Females (50s) 371 (24.5%) 696 7 686 11 216 7 476 7 496 8
Females (60s) 213 (14.1%) 716 7 646 10 196 7 456 7 496 8
Females (70s) 39 (2.6%) 726 6 616 9 186 5 436 6 486 8
The presented data (mean6 SD) are stratified by gender and also by age decades. Normalization of the absolute values to body sur-
face area was performed using the Mosteller formula. EF 5 ejection fraction, EDV 5 end diastolic volume, ESV 5 end systolic vol-
ume, SV 5 stroke volume, LVM 5 left ventricular mass, EDVI 5 end diastolic volume index, ESVI 5 end systolic volume index,
SVI 5 stroke volume index, LVMI 5 left ventricular mass index. Statistically significant differences were detected for all mean LV
variables between the male (n 5 574) and female (n 5 941) cohorts (P < 0.05).
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When the LV variables were subdivided into age
decade categories (40s, 50s, 60s, and 70s) a number of
age-related changes were evident. For males, the mean
EF rose slightly over the first decade studied (11%, P <
0.04) but then remained stable across the remaining age
decades. However, the means of all other variables were
reduced with age (Fig. 1) (40s vs. 70s; EDVI and SVI
P < 0.05).
For females, the mean EF rose marginally with age (a
4.0% increase was noted in the 70 years cohort relative to
the 40–49 years cohort) but the means of all other volumet-
ric variables were noted to decrease with age (40s vs. 70s;
EDVI, ESVI, SVI P < 0.05). The most stable of all the var-
iables was found to be the mean LVMI, which was only
reduced by 1 g/m2 in the 70 years cohort relative to the
40s cohort. This pattern appeared different from that
observed in the male cohort, which demonstrated a more
defined reduction in mean LVMI with age.
The results of regression analysis describing the linear
change of each LV variable per decade of age are highlighted
in Table 3. All variables except for EF were noted to
decrease with age, and the EDVI showed the biggest “per
decade” reduction (–2.9 6 1.3 ml/m2 for males and –3.1
6 0.8 ml/m2 for females). The biggest difference between
the male and female population was noted for LVMI, where
greater “per decade” losses were measured in the male
cohort (–1.6 6 1.1 g/m2) relative to the female cohort,
which remained virtually stable (–0.2 6 0.6 g/m2).
A total of n 5 782 volunteers satisfied the more stringent
low-risk factor inclusion criteria for the subset cohort, and the
resulting data are presented in Appendices 1 (demographics)
and 2 (MR parameters). There were no statistically significant
differences between the means of any of the normalized LV var-
iables when the data from the full cohort and the subset cohort
were compared (P > 0.05 for all LV variables, including all
comparisons when subdivided by gender and age).
The variation in normalized mean LV measurements
between the different segmentation observers is detailed in
Table 4, and illustrated graphically in Fig. 2 for LVM (the
most variable measurement). Although the group of volun-
teers segmented by each observer was different in each case,
the data were stratified by age and gender, and normalized
to BSA in order to make comparisons closely related to the
segmentation technique itself. The consistency of the data
between observers for mean EF data ranged from 66 6 6%
(observer 5) to 71 6 5% (observer 1) for males, and from
68 6 7% (observer 4) to 73 6 5% (observer 1) for females.
These were similar to the mean EF for the full cohort
(Table 2) of 69 6 6%. For the LV mass index, the consis-
tency of the data ranged from 61 6 9 g/m2 (observer 4), to
69 6 11 g/m2 (observer 2) for males, and from 45 6 6 g/
m2 (observer 4) to 55 6 7 g/m2 (observer 2) for females.
FIGURE 1: A plot of mean ejection fraction (EF), end-diastolic
volume (EDV), end-systolic volume (ESV), stroke volume (SV),
and left ventricular mass (LVM) showing the change of each
variable with age in males and females for cohorts in the
age ranges 50–59 years (50s), 60–69 years (60s) and over
70 years (70s), relative to the baseline 40–49 years (40s)
cohort.
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These also compare favorably to the mean LV mass index
for the entire cohort (Table 2) of 55 6 12 g/m2.
Finally, a comparison of the 3.0T data with 1.5T data
from elsewhere is presented in table 5. The mean EF was
found to be marginally greater at 3.0T relative to 1.5T, but
for all other variables the means were a little lower at 3.0T.
Discussion
In this study we present data describing MR LV structure
and function in a large cohort of volunteers. The study
methodology is similar to others performed previously.1–3
This work was prepared in response to the specific need for
3.0T MR data of this type as recently reported by Kawel-
TABLE 3. Results of Linear Regression Analysis Performed on the Male and Female Cohorts in Order to Derive
“Per Decade” Change for Each of the Measured Indexed LV Variables
Correlation
Coefficient
r (95% CI)
Slope
(95% CI)
y-intercept Per Decade
Change
(95% CI)
Male Age (x-variable)
EF (%) 0.08 0.06 64.66 0.6 (60.6)
EDVI (ml/m2) 20.18 20.29 92.67 22.9 (61.3)
ESVI (ml/m2) 20.14 20.13 31.81 21.3 (60.7)
SVI (ml/m2) 20.15 20.17 60.86 21.7 (60.9)
LVMI (g/m2) 20.13 20.16 72.69 21.6 (61.1)
Female Age (x-variable)
EF (%) 0.15 0.12 62.87 1.2 (60.5)
EDVI (ml/m2) 20.25 20.31 84.45 23.1 (60.8)
ESVI (ml/m2) 20.22 20.17 30.18 21.7 (60.5)
SVI (ml/m2) 20.17 20.14 54.27 21.4 (60.6)
LVMI (g/m2) 20.02 20.02 49.91 20.2 (60.6)
TABLE 4. LV Structure and Function Data (Mean 6 SD) as Derived by Each of the Six Segmentation Observers
No.
Volunteers
Mean
Age (yrs)
EF
(%)
EDVI
(ml/m2)
ESVI
(ml/m2)
SVI
(ml/m2)
LVMI
(g/m2)
Males - Obs 1 102 (6.7%) 556 9 716 5 746 12 226 6 526 8 646 8
Males - Obs 2 106 (7.0%) 546 8 686 5 746 13 246 6 506 9 696 11
Males - Obs 3 95 (6.3%) 536 8 686 5 796 12 256 6 546 8 636 12
Males - Obs 4 90 (5.9%) 566 8 676 7 796 15 276 9 536 10 616 9
Males - Obs 5 70 (4.6%) 556 8 666 6 786 16 266 8 526 11 656 12
Males - Obs 6 111 (7.3%) 546 8 676 7 766 12 266 8 516 8 626 9
Females - Obs 1 164 (10.8%) 546 8 736 5 646 10 176 5 466 7 496 7
Females - Obs 2 145 (9.6%) 556 9 706 6 666 10 206 6 466 7 556 7
Females - Obs 3 154 (10.2%) 556 8 686 6 706 11 226 6 476 7 486 8
Females - Obs 4 161 (10.6%) 546 8 696 6 696 11 226 6 486 7 456 6
Females - Obs 5 180 (11.9%) 546 9 686 7 706 11 236 8 476 8 516 9
Females - Obs 6 137 (9.0%) 556 8 686 7 656 10 216 7 446 6 456 7
EF 5 ejection fraction, EDVI 5 end diastolic volume, ESVI 5 end systolic volume, SVI 5 stroke volume, LVMI 5 left ventricular
mass.
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Boehm et al.11 Statistical limitations associated with small
study cohorts have been addressed by extending this work
to include a large asymptomatic population, with full cover-
age across the adult age range to account for remodeling
processes associated with the heart that occur with age.
In this study the means and ranges obtained for LV
structure and function parameters at 3.0Tare generally similar
to those reported at 1.5T. The mean EF was marginally
greater at 3.0T relative to 1.5T, but for all other variables the
means were a little lower at 3.0T. The reason for these differ-
ences is not clear but may be related to variations in edge
boundary perception due to changes in the T1 (and T2) relax-
ation times of the blood pool, myocardium, and other sur-
rounding tissue structures. There may also be small
differences in our study cohort demographics in relation to
those reported from elsewhere. The greatest differences were
noted for female volunteers, where the mean EDV and LVM
parameters were 12 ml and 11 g lower, respectively, at 3.0T
when compared to the previous pooled 1.5T data reported by
Kawel-Boehm et al.11 If the individual articles that contribute
to this published range are scrutinized more closely, the best
agreement to our 3.0T mean EDV (120 ml) is found in the
work by Maciera et al,3 who obtained a mean EDVof 126 ml
for their cohort of female volunteers in the 50–59 years age
decade at 1.5T. Similarly, the closest agreement to our mean
LVM (87 g) is reported in the work by Alfakih et al,1 who
TABLE 5. Comparison of Data Acquired at 1.5T (Taken From Ref. 11) With That Acquired in This Study
LV 1.5T 1.5T 1.5T 3.0T 3.0T 3.0T Difference
Variable Mean SD Range Mean SD Range 1.5T -3.0T
MALES EF (%) 67 5 57–77 68 6 55–80 21
EDV (ml) 160 27 106–214 155 28 100–210 5
ESV (ml) 54 14 26–82 50 15 21–80 4
SV (ml) 108 18 72–144 105 19 67–143 3
LVM (g) 134 21 92–176 129 24 81–178 5
EDVI (ml/m2) 81 12 57–105 77 13 50–103 4
ESVI (ml/m 2) 26 6 14–38 25 7 10–40 1
SVI (ml/m2) 54 6 42–66 52 9 34–70 2
LVMI (g/m 2) 67 9 49–85 64 10 43–85 3
FEMALES EF (%) 67 5 57–77 69 7 56–83 22
EDV (ml) 132 23 86–178 120 21 78–162 12
ESV (ml) 44 11 22–66 37 12 13–61 7
SV (ml) 87 15 57–117 82 14 54–111 5
LVM (g) 98 21 56–140 87 17 54–120 11
EDVI (ml/m2) 76 10 56–96 68 11 46–89 8
ESVI (ml/m 2) 24 5 14–34 21 7 8–34 3
SVI (ml/m2) 52 7 38–66 46 7 32–61 6
LVMI (g/m 2) 61 10 41–81 49 8 33–65 12
Data are presented as the mean, SD, and range (defined as 6 2 SD of the mean). With the exception of EF, the calculated figures at
3.0T were all lower than those previously published at 1.5T and the difference was clearer in the female volunteer cohort.
FIGURE 2: Variation in mean left ventricular mass index (LVMI;
6 SD) between the different observers who participated in the
data analysis. Of note is that observer 2 consistently derived
the largest LVMI values and observer 4 consistently derived
the smallest LVMI values. These data do not represent “true
interobserver variation” since each study cohort was different
for each observer. However, by using the LVMI and stratifying
by gender, the component of the variation due to different
cohort sizes and gender ratios has been minimized.
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obtained a mean LVM of 88.1 g for their cohort of female
volunteers in the 40–65 years age range at 1.5T. In other
words, although some discrepancy exists between the pooled
1.5T data, there are individual contributions that agree quite
closely with our findings at 3.0T.
When our 3.0T data were subdivided into male and
female groups, the mean data for females were significantly
lower than the means for males in all parameters studied,
except for EF. This is expected and consistent with findings
reported elsewhere.2 Alternative subdivision of the data into
age decades (40s, 50s, 60s, and 70s) revealed that mean EF
was virtually stable with age in males but rose a little with
increasing age in females. Conversely, the mean LVMI was
virtually stable with age in females but reduced with age in
males. The other mean variables (EDVI, ESVI, and SVI)
were found to reduce with age by varying amounts. These
patterns of change over time are most similar to those
reported by Hudsmith et al2 at 1.5T, where they compared
cohorts of volunteers in groups with age stratification <35
years and >35 years. Similar patterns of change over time are
also presented by Alfakih et al1 and Macieira et al3 at 1.5T.
The normalization of cardiac structure and function
data is a complex area, and many approaches have been
reported. Normalization to height,25 fat-free mass (FFM),26
and weight27 have been proposed, but the method most
commonly employed is normalization to BSA.28 The Mos-
teller index to BSA was chosen for this work since it is rela-
tively simple, widely used, and validated on a wide range of
subject sizes. Other normalization methods such as that pro-
posed by DuBois and DuBois29 are also available, but this
latter study was only validated on very small cohorts and is
considered to be less meaningful at the lower and upper
ranges of height and weight combinations.
In order to maintain optimal consistency, the study
was conducted over a 5-year period using the same scanner
and the same RF coil combinations. No significant down-
time was experienced over the duration of the work and the
only minor change to the system over this period was an
upgrade from software version VB15 to VB17, which did
not noticeably affect the functionality of the MR protocols
and analysis packages used. To this end, the experimental
equipment was considered to remain stable for the duration
of the experiment.
The data were acquired over such a large cohort that we
elected to use multiple observers for the segmentation analy-
sis. Each observer (six in total) was responsible for segmenting
approximately n 5 250 datasets. These data were stratified by
gender and normalized to BSA (using the Mosteller formula)
in order to account for body habitus variations between each
of the cohorts allocated to each of the segmentation observers.
This approach enables the variations in each LV parameter to
be attributable to the segmentation technique, and not be
influenced by the physical size or gender distribution of the
cohort populations. The mean age of the cohorts allocated to
each segmentation observer is also closely matched, which has
ensured further consistency, ie, the segmentation technique
itself is the dominant factor that forms the variation between
observers. Although the segmentation technique was agreed
beforehand and all observers were experienced, some real-
world differences between observers were apparent. The mean
EF was slightly larger (and the ESVI slightly lower) for volun-
teers segmented by observer 1, suggesting that the observer
was heavily excluding papillary muscles at end-systole from
the ESV blood pool volume. Similarly, the range of values for
mean LVMI was variable in places, with observer 4 tending to
generate slightly smaller mean values. While some of this vari-
ation may be due to the fact that different volunteers were
included in each cohort (an accepted limitation of the study
design), the likelihood is that it is mostly down to subtle var-
iations in the segmentation technique between the observers
(similar variability figures are reported in studies by Chuang
et al30 and Suinesiaputra et al31). It was, however, most
encouraging to note that the generated data were generally
very similar between all of the observers.
The use of a 3.0T scanner for this work was proposed
on the basis that the theoretical improvement to the signal-to-
noise ratio might be traded for faster scanning (ie, more LV
SA slices per breath-hold) and therefore faster volunteer
throughput. However, in reality much of the “time saved”
(relative to 1.5T) was required for the process of image opti-
mization, eg, the use of optimized volunteer-specific shim-
ming techniques (eg, “frequency scout”) and targeted shim
regions placed over the area of interest during the examination
in order to eradicate resonant-offset banding and flow-related
artifacts. Although relatively little “time-saving” was achieved,
the comparison with existing 1.5T data should help to pro-
vide support data for future population-based research studies
that may utilize scanners at both field strengths.
Limitations of the study include the fact that the soft-
ware used was not easily able to account for papillary mus-
cle volumes, leading to possible small variation between
observers as to how the papillary structures would in prac-
tice be treated. A further limitation of the study is that no
direct equivalent 1.5T data were available and no spoiled
gradient echo data were acquired for comparative purposes.
The size of the study was such that this was considered pro-
hibitive in terms of time, but similar comparisons are avail-
able in the existing literature for 1.5T data12 and it is likely
that similar trends would be seen at 3.0T. Finally, it is
accepted that the inclusion criteria used to identify certain
risk factors associated with CVD during the recruitment
phase were a little more relaxed than current recommenda-
tions. The decision to select asymptomatic volunteers with a
BNP greater than the gender-specific median was made
with a view to undertaking further MR examinations on the
same volunteer cohort as they become older. However, the
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risk of this significantly confounding the results of this
study is minimal: we have knowingly excluded anybody
with clinically apparent CVD in this work, and in
addition to which there were no statistical differences
detected within any of the cardiac MR parameters when
only those with a BNP <2 SD above the gender-specific
APPENDIX 1. Demographic information related to anatomical size for a subset of volunteers (n 5 782) with
lower risk factors for CVD, based on 1) BP <140/90 mmHg, 2) nonsmokers, and 3) BNP <2 SD above the original
cohort gender-specific mean.
ABSOLUTE No
Volunteers
Height
(m)
Weight
(kg)
BMI
(kg/m2)
BSA
(Mosteller)
BSA
(DuBois)
All 782 1.68 (0.10) 74.99 (14.30) 26.09 (4.23) 1.87 (0.21) 1.85 (0.20)
Males 299 1.78 (0.07) 83.78 (11.26) 26.47 (3.21) 2.03 (0.16) 2.02 (0.15)
Females 483 1.64 (0.07) 69.30 (13.13) 25.85 (4.74) 1.77 (0.18) 1.75 (0.16)
Males (40s) 118 1.79 (0.07) 85.37 (11.24) 26.60 (3.35) 2.06 (0.15) 2.04 (0.15)
Males (50s) 135 1.77 (0.07) 83.64 (11.51) 26.64 (3.09) 2.02 (0.16) 2.01 (0.16)
Males (60s) 38 1.77 (0.07) 79.45 (10.09) 25.38 (3.12) 1.97 (0.14) 1.96 (0.13)
Males (70s) 8 1.76 (0.04) 83.08 (8.20) 26.89 (3.01) 2.01 (0.10) 1.99 (0.09)
Females (40s) 176 1.65 (0.06) 70.68 (13.78) 26.14 (4.84) 1.79 (0.19) 1.77 (0.17)
Females (50s) 185 1.64 (0.07) 70.36 (13.74) 26.24 (5.09) 1.78 (0.18) 1.76 (0.16)
Females (60s) 107 1.63 (0.07) 65.90 (10.53) 24.89 (3.90) 1.72 (0.15) 1.71 (0.14)
Females (70s) 15 1.62 (0.07) 64.43 (9.75) 24.70 (3.89) 1.70 (0.15) 1.68 (0.14)
APPENDIX 2. LV structure and function data acquired in the n 5 782 subset of volunteers. When compared with
the equivalent normalized data acquired from the whole cohort (Table 2), there were no significant differences
between the means of any variable (P > 0.05 for all data, including subcomparisons stratified by age and gender).
ABSOLUTE No Volunteers EF (%) EDV (ml) ESV (ml) SV (ml) LVM (g)
All 782 69 6 6 134 6 29 43 6 14 92 6 19 102 6 28
Males 299 67 6 6 158 6 25 52 6 14 106 6 18 128 6 22
Females 483 70 6 6 119 6 20 37 6 11 83 6 14 86 6 16
Males (40s) 118 66 6 6 165 6 26 56 6 13 109 6 20 133 6 24
Males (50s) 135 68 6 6 154 6 24 49 6 14 104 6 17 126 6 20
Males (60s) 38 68 6 7 153 6 24 50 6 17 103 6 14 123 6 19
Males (70s) 8 67 6 4 154 6 12 51 6 10 102 6 7 121 6 13
Females (40s) 176 68 6 5 125 6 20 40 6 11 85 6 13 86 6 15
Females (50s) 185 70 6 6 121 6 20 37 6 10 84 6 14 87 6 17
Females (60s) 107 71 6 6 109 6 15 31 6 9 78 6 12 84 6 14
Females (70s) 15 73 6 5 105 6 21 29 6 9 76 6 13 81 6 14
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mean (and therefore associated with normal limits) were
included in the analysis.
In conclusion, we describe LV reference ranges in a
population-based MR study of volunteers asymptomatic of
CVD at 3.0T. The resulting figures are similar to those nor-
mal ranges previously reported at 1.5T, and changes with
age and gender also follow similar patterns. Data acquired
from the full cohort are very similar to those derived from a
subgroup with lower risk factors for CVD, suggesting that
CVD risk at these levels does not contribute a significant
effect. These baseline data might also enable future monitor-
ing of LV changes over time as/when individuals within the
cohort require future MR examinations.
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